Inmaculada Dona

Malaga, AN, Spain

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 127 publications

Correction: Jiménez-Sánchez et al. Antioxidant Enzymes Genetic Variants Associated with Urticaria/Angioedema Induced by Cross-Reactive Hypersensitivity to Nonsteroidal Anti-Inflammatory Drugs. Pharmaceuticals 2026, 19, 522.

Correction: Jiménez-Sánchez et al. Antioxidant Enzymes Genetic Variants Associated with Urticaria/Angioedema Induced by Cross-Reactive Hypersensitivity to Nonsteroidal Anti-Inflammatory Drugs. Pharmaceuticals 2026, 19, 522.

Journal: Pharmaceuticals (Basel, Switzerland)
Published: May 27, 2026

Nomenclature on Immune-Mediated Drug Reactions: An EAACI Position Paper.

Nomenclature on Immune-Mediated Drug Reactions: An EAACI Position Paper.

Journal: Allergy
Published: May 06, 2026

Antioxidant Enzymes Genetic Variants Associated with Urticaria/Angioedema Induced by Cross-Reactive Hypersensitivity to Nonsteroidal Anti-Inflammatory Drugs.

Antioxidant Enzymes Genetic Variants Associated with Urticaria/Angioedema Induced by Cross-Reactive Hypersensitivity to Nonsteroidal Anti-Inflammatory Drugs.

Journal: Pharmaceuticals (Basel, Switzerland)
Published: March 04, 2026

Machine Learning Model Development and Validation in Individuals With Suggestive Hypersensitivity to Nonsteroidal Anti-inflammatory Drugs.

Machine Learning Model Development and Validation in Individuals With Suggestive Hypersensitivity to Nonsteroidal Anti-inflammatory Drugs.

Journal: Journal of investigational allergology & clinical immunology
Published: February 09, 2026

Reply.

Reply.

Journal: The Journal of allergy and clinical immunology
Published: December 20, 2025

Development of Betalactam-Predictor: A Clinical Decision Tool for Delabeling Low-Risk Betalactam Allergy Patients. Initial Validation in Penicillin Allergy.

Development of Betalactam-Predictor: A Clinical Decision Tool for Delabeling Low-Risk Betalactam Allergy Patients. Initial Validation in Penicillin Allergy.

Journal: Allergy
Published: August 20, 2025

Diagnosis and Management of Hypersensitivity to Antiplatelet Drugs: EAACI Position Paper.

Diagnosis and Management of Hypersensitivity to Antiplatelet Drugs: EAACI Position Paper.

Journal: Allergy
Published: April 23, 2025

Allergological Work-Up in Cephalosporin Allergy Diagnosis and Delabelling: The Experience From Two European Allergy Centres.

Allergological Work-Up in Cephalosporin Allergy Diagnosis and Delabelling: The Experience From Two European Allergy Centres.

Journal: Allergy
Published: April 16, 2025

Nonsteroidal anti-inflammatory drug-induced acute urticaria/angioedema associated with atopy-related genes' genetic variants.

Nonsteroidal anti-inflammatory drug-induced acute urticaria/angioedema associated with atopy-related genes' genetic variants.

Journal: The Journal of allergy and clinical immunology
Published: March 18, 2025

Reply to Correspondence: What Is the Next Step for Patients With Aspirin-Exacerbated Respiratory Disease: Biologics With or Without Aspirin Therapy?

Reply to Correspondence: What Is the Next Step for Patients With Aspirin-Exacerbated Respiratory Disease: Biologics With or Without Aspirin Therapy?

Journal: Allergy
Published: January 31, 2025

Updating the classification and routine diagnosis of NSAID hypersensitivity reactions: A WAO Statement.

Updating the classification and routine diagnosis of NSAID hypersensitivity reactions: A WAO Statement.

Journal: The World Allergy Organization journal
Published: January 30, 2025

Resensitization-Should Repeat Testing Be Performed in Patients Undergoing Penicillin Allergy Evaluations? A Pro-Con Debate.

Resensitization-Should Repeat Testing Be Performed in Patients Undergoing Penicillin Allergy Evaluations? A Pro-Con Debate.

Journal: The journal of allergy and clinical immunology. In practice
Published: October 25, 2024
Showing 1-12 of 127

Last Updated: 09/26/2026